Tuesday, September 13, 2011

MicroRNA-23 Restricts Cardiac Valve Formation by Inhibiting Has2 and Extracellular Hyaluronic Acid Production.

MicroRNA-23 Restricts Cardiac Valve Formation by Inhibiting Has2 and Extracellular Hyaluronic Acid Production.
Conclusions: MiR-23 in the embryonic heart is required to restrict endocardial cushion formation by inhibiting Has2 expression and extracellular hyaluronic acid production. PMID: 21778427 [PubMed - as supplied by publisher] (Source: Circulation Research)

MedWorm Message: Find out how you can get your message posted here and on over 100,000 other medical web pages in just a couple of days, plus support MedWorm at the same time.




Die Patientinnen und Patienten k�nnen im Zuge der modernen plastischen und �sthetischen Chirurgie auf die Botox Preise vertrauen.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.